메뉴 건너뛰기




Volumn 87, Issue 12, 2009, Pages 834-842

Increased risk of earlypregnancy loss and lower live birth rate with GnRH antagonist vs long GnRH agonist protocol in PCOS women undergoing controlled ovarian hyperstimulation;Augmentation du taux de fausses couches spontanees precoces et diminution du taux de naissances vivantes avec le protocole antagoniste de la GnRH versus agoniste long chez les patientes porteuses d'un syndrome des ovaires polykystiques

Author keywords

GnRH agonists; GnRH antagonists; ICSI; PCOS

Indexed keywords

CETRORELIX; ESTRADIOL; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; LUTEINIZING HORMONE; ORAL CONTRACEPTIVE AGENT; RECOMBINANT FOLLITROPIN; TRIPTORELIN;

EID: 77649257685     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (16)

References (39)
  • 1
    • 33750210002 scopus 로고    scopus 로고
    • Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis
    • Kolibianakis EM, Collins J, Tarlatzis BC, Devroey P, Diedrich K, Griesinger G. Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Hum Reprod Update 2006; 12: 651-71.
    • (2006) Hum Reprod Update , vol.12 , pp. 651-671
    • Kolibianakis, E.M.1    Collins, J.2    Tarlatzis, B.C.3    Devroey, P.4    Diedrich, K.5    Griesinger, G.6
  • 2
    • 34248652678 scopus 로고    scopus 로고
    • Gonadotrophinreleasing hormone antagonists for assisted conception. A Cochrane review
    • Al-Inany HG, Abou-Setta AM, Aboulghar M. Gonadotrophinreleasing hormone antagonists for assisted conception. A Cochrane review. Reprrod Biomed Online 2007; 14:640-9.
    • (2007) Reprrod Biomed Online , vol.14 , pp. 640-649
    • Al-Inany, H.G.1    Abou-Setta, A.M.2    Aboulghar, M.3
  • 3
    • 34447318868 scopus 로고    scopus 로고
    • Initiation of GnRH antagonist on Day 1 of stimulation as compared to the long agonist protocol in PCOS patients. A randomized controlled trial: Effect on hormonal levels and follicular development
    • Lainas TG, Petsas GK, Zorzovilis IZ, Iliadis GS, Lainas GT, Cazlaris HE, Kolibianakis EM. Initiation of GnRH antagonist on Day 1 of stimulation as compared to the long agonist protocol in PCOS patients. A randomized controlled trial: effect on hormonal levels and follicular development. Hum Reprod 2007; 22 :1540-6.
    • (2007) Hum Reprod , vol.22 , pp. 1540-1546
    • Lainas, T.G.1    Petsas, G.K.2    Zorzovilis, I.Z.3    Iliadis, G.S.4    Lainas, G.T.5    Cazlaris, H.E.6    Kolibianakis, E.M.7
  • 4
    • 39049131625 scopus 로고    scopus 로고
    • Comparison of oocyte quality and intracytoplasmic sperm injection outcome in women with isolated polycystic ovaries or polycystic ovarian syndrome
    • Sahu B, Ozturk O, Ranierri M, Serhal P. Comparison of oocyte quality and intracytoplasmic sperm injection outcome in women with isolated polycystic ovaries or polycystic ovarian syndrome. Arch Gynecol Obstet. 2008; 277: 239-44.
    • (2008) Arch Gynecol Obstet , vol.277 , pp. 239-244
    • Sahu, B.1    Ozturk, O.2    Ranierri, M.3    Serhal, P.4
  • 5
    • 4544286633 scopus 로고    scopus 로고
    • The Rotterdam ESHRE/ASRM-Sponsored PCOS. Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome
    • The Rotterdam ESHRE/ASRM-Sponsored PCOS. Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome. Hum Reprod 2004; 81: 19-25.
    • (2004) Hum Reprod , vol.81 , pp. 19-25
  • 6
    • 0026763156 scopus 로고
    • Ovarian hyperstimulation syndrome in novel reproductive technologies : Prevention and treatment
    • Navot D, Bergh PA, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies : prevention and treatment. Fertil Steril 1992 ; 58 : 249-61.
    • (1992) Fertil Steril , vol.58 , pp. 249-261
    • Navot, D.1    Bergh, P.A.2    Laufer, N.3
  • 7
    • 24044551348 scopus 로고    scopus 로고
    • Comparaison of GnRH agonists in assisted reproduction cycles of patients at high risk of ovarian hyperstimulation syndrome
    • Ragni G, Vegetti W, Riccaboni A, Engl B, Brigante C, Crosignani PG. Comparaison of GnRH agonists in assisted reproduction cycles of patients at high risk of ovarian hyperstimulation syndrome. Human Reproduction 2005; 20: 2421-5.
    • (2005) Human Reproduction , vol.20 , pp. 2421-2425
    • Ragni, G.1    Vegetti, W.2    Riccaboni, A.3    Engl, B.4    Brigante, C.5    Crosignani, P.G.6
  • 8
    • 13444283607 scopus 로고    scopus 로고
    • Use of GnRH antagonist in controlled ovarian hyperstimulation for assisted conception in women with polycystic ovary disease: A randomized, prospective, pilot study
    • Bahceci M, Ulug U, Ben-Shlomo I, Erden HF, Akman M. Use of GnRH antagonist in controlled ovarian hyperstimulation for assisted conception in women with polycystic ovary disease: a randomized, prospective, pilot study. Journal of reproductive medicine 2005; 50: 84-90.
    • (2005) Journal of reproductive medicine , vol.50 , pp. 84-90
    • Bahceci, M.1    Ulug, U.2    Ben-Shlomo, I.3    Erden, H.F.4    Akman, M.5
  • 9
    • 0035070776 scopus 로고    scopus 로고
    • Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation
    • The European and meaddle East Orgalutran Study Group
    • The European and meaddle East Orgalutran Study Group. Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation. Hum Reprod 2001; 16: 644-51.
    • (2001) Hum Reprod , vol.16 , pp. 644-651
  • 10
    • 0033807688 scopus 로고    scopus 로고
    • Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient results of a controlled, randomized, multicentre trial
    • The European Orgalutran Study Group
    • The European Orgalutran Study Group. Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient results of a controlled, randomized, multicentre trial. Hum Reprod 2000; 15: 1490-8.
    • (2000) Hum Reprod , vol.15 , pp. 1490-1498
  • 11
    • 0035161913 scopus 로고    scopus 로고
    • Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation
    • The North American Ganirelix Study Group
    • The North American Ganirelix Study Group. Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation. Fertil Steril 2001; 75: 38-45.
    • (2001) Fertil Steril , vol.75 , pp. 38-45
  • 12
    • 52949126768 scopus 로고    scopus 로고
    • Oral contraceptive pill pretreatment in ovarian stimulation with GnRH antagonists for IVF. A systematic review and meta-analysis
    • Griesinger G, Venetis CA, Marx T, Diedrich K, Tarlatzis BC, Kolibianakis EM. Oral contraceptive pill pretreatment in ovarian stimulation with GnRH antagonists for IVF. A systematic review and meta-analysis. Fertil Steril 2008; 90: 1055-63.
    • (2008) Fertil Steril , vol.90 , pp. 1055-1063
    • Griesinger, G.1    Venetis, C.A.2    Marx, T.3    Diedrich, K.4    Tarlatzis, B.C.5    Kolibianakis, E.M.6
  • 13
    • 0034053260 scopus 로고    scopus 로고
    • Ovarian stimulation with HMG: Results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)- antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group
    • Albano C, Felberbaum RE, Smitz J, et al. Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)- antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group. Hum Reprod 2000; 15: 526-31.
    • (2000) Hum Reprod , vol.15 , pp. 526-531
    • Albano, C.1    Felberbaum, R.E.2    Smitz, J.3
  • 14
    • 0033954654 scopus 로고    scopus 로고
    • Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LR-RH agonist (triptorelin)
    • Olivennes F, Belaisch-Allart J, Emperaire JC et al. Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LR-RH agonist (triptorelin). Fertil Steril 2000; 73: 314-20.
    • (2000) Fertil Steril , vol.73 , pp. 314-320
    • Olivennes, F.1    Belaisch-Allart, J.2    Emperaire, J.C.3
  • 15
    • 0027177975 scopus 로고
    • The ovarian hyperstimulation syndrome in in-vitro fertilization. A Belgian multicentric study.II. Multiple descriminant analysis for risk prediction
    • Delvigne A, Dubois M, Battheu B, Bassil S, Meuleman C, De Sutter P, et al. The ovarian hyperstimulation syndrome in in-vitro fertilization. A Belgian multicentric study.II. Multiple descriminant analysis for risk prediction. Hum Reprod 1993; 8: 1361-6.
    • (1993) Hum Reprod , vol.8 , pp. 1361-1366
    • Delvigne, A.1    Dubois, M.2    Battheu, B.3    Bassil, S.4    Meuleman, C.5    De Sutter, P.6
  • 16
    • 33751116124 scopus 로고    scopus 로고
    • GnRH antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation. A meta-analysis
    • Griesinger G, Diedrich K, Tarlatzis BC, Kolibianakis EM. GnRH antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation. A meta-analysis. Reprod Biomed Online 2006; 13: 628-38.
    • (2006) Reprod Biomed Online , vol.13 , pp. 628-638
    • Griesinger, G.1    Diedrich, K.2    Tarlatzis, B.C.3    Kolibianakis, E.M.4
  • 17
    • 34250723951 scopus 로고    scopus 로고
    • Review of the evidence base of strategies to prevent ovarian hyperstimulation syndrome
    • Mathur R, Kailsasam C, Jenkins J. Review of the evidence base of strategies to prevent ovarian hyperstimulation syndrome. Hum Fertil 2007;10:75-85.
    • (2007) Hum Fertil , vol.10 , pp. 75-85
    • Mathur, R.1    Kailsasam, C.2    Jenkins, J.3
  • 18
    • 55549091370 scopus 로고    scopus 로고
    • Alcione L.A. Silva, Lauriane G.A. Abreu, Ana Carolina J.S. Rosae- Silva, Rui A. Ferriani, Marcos F. Leuprolide acetate reduces both in vivo and in vitro ovarian steroidogenesis in infertile women. Steroids 2008; 73: 1475-1484.
    • Alcione L.A. Silva, Lauriane G.A. Abreu, Ana Carolina J.S. Rosae- Silva, Rui A. Ferriani, Marcos F. Leuprolide acetate reduces both in vivo and in vitro ovarian steroidogenesis in infertile women. Steroids 2008; 73: 1475-1484.
  • 19
    • 34548762590 scopus 로고    scopus 로고
    • Prospective randomized study comparing coasting with GnRH antagonist administration in patients at risk for severe OHSS
    • Aboulghar MA, Mansour RT, Amin YM, Al-Inany HG, Aboulghar MM, Serour GI. Prospective randomized study comparing coasting with GnRH antagonist administration in patients at risk for severe OHSS. Reprod Biomed Online 2007; 15: 271-9.
    • (2007) Reprod Biomed Online , vol.15 , pp. 271-279
    • Aboulghar, M.A.1    Mansour, R.T.2    Amin, Y.M.3    Al-Inany, H.G.4    Aboulghar, M.M.5    Serour, G.I.6
  • 20
    • 34447325975 scopus 로고    scopus 로고
    • Triggering of final oocyte maturation with gonadotrophin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles
    • Griesinger G, Kolibianakis EM, Papanikolaou EG, Diedrich K, Van steirteghem A, Devroey P. Triggering of final oocyte maturation with gonadotrophin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles. Fertil Steril 2007; 88: 616-21.
    • (2007) Fertil Steril , vol.88 , pp. 616-621
    • Griesinger, G.1    Kolibianakis, E.M.2    Papanikolaou, E.G.3    Diedrich, K.4    Van steirteghem, A.5    Devroey, P.6
  • 21
    • 20944434996 scopus 로고    scopus 로고
    • In vitro oocyte maturation for the treatment of infertility associated with polycystic ovarian syndrome. The french experience
    • Le Du A, Kadoch IJ, Bourcigaux N, Doumerc S, Bourrier MC, Chevalier N, et al. In vitro oocyte maturation for the treatment of infertility associated with polycystic ovarian syndrome. The french experience. Hum Reprod 2005; 20: 420-4.
    • (2005) Hum Reprod , vol.20 , pp. 420-424
    • Le Du, A.1    Kadoch, I.J.2    Bourcigaux, N.3    Doumerc, S.4    Bourrier, M.C.5    Chevalier, N.6
  • 22
    • 0038265887 scopus 로고    scopus 로고
    • Gonadotrophin-releasing hormone antagonist: Will they replace the agonists?
    • Felberbaum RE, Diedrich K. Gonadotrophin-releasing hormone antagonist: will they replace the agonists? Reprod Biomed Online 2003; 6: 43-53.
    • (2003) Reprod Biomed Online , vol.6 , pp. 43-53
    • Felberbaum, R.E.1    Diedrich, K.2
  • 23
    • 0029954772 scopus 로고    scopus 로고
    • Triggering of ovulation by a gonadotropin-releasing hormone (GnRH) agonist in patients pretreated with a GnRH antagonist
    • Olivennes F, Fanchin R, Bouchard P, Taieb J, Frydman R. Triggering of ovulation by a gonadotropin-releasing hormone (GnRH) agonist in patients pretreated with a GnRH antagonist. Fertil Steril 1996; 66: 151-3.
    • (1996) Fertil Steril , vol.66 , pp. 151-153
    • Olivennes, F.1    Fanchin, R.2    Bouchard, P.3    Taieb, J.4    Frydman, R.5
  • 25
    • 0029919566 scopus 로고    scopus 로고
    • Impaired estrogen action in the uterus og IGF binding protein-1 transgenic mice
    • Rajkumar K, Dheen T, Kresk M, Murphu LJ. Impaired estrogen action in the uterus og IGF binding protein-1 transgenic mice. Endocrinology 1996; 137: 1258-64.
    • (1996) Endocrinology , vol.137 , pp. 1258-1264
    • Rajkumar, K.1    Dheen, T.2    Kresk, M.3    Murphu, L.J.4
  • 26
    • 0024437934 scopus 로고
    • IGFII and short- range stimulatory loops in control of human placental growth
    • Ohlsson R, Holmgren L, Glaser A, Szpecht A, Pfeifer-Ohlsson S. IGFII and short- range stimulatory loops in control of human placental growth. EMBO J 1989; 8: 1993-9.
    • (1989) EMBO J , vol.8 , pp. 1993-1999
    • Ohlsson, R.1    Holmgren, L.2    Glaser, A.3    Szpecht, A.4    Pfeifer-Ohlsson, S.5
  • 28
    • 43649108594 scopus 로고    scopus 로고
    • GnRH antagonists may affect endometrial receptivity.Fertil Steril
    • Rackow BW, Kliman HJ, Taylor HS. GnRH antagonists may affect endometrial receptivity.Fertil Steril 2008;89:1234-9.
    • (2008) , vol.89 , pp. 1234-1239
    • Rackow, B.W.1    Kliman, H.J.2    Taylor, H.S.3
  • 30
    • 0347418287 scopus 로고    scopus 로고
    • Gonadotropin-releasing hormone (GnRH)-antagonist versus GnRH-agonist in ovarian stimulation of poor responders undergoing IVF
    • Fasioloutis SJ, Laufer N, Sabbagh-Ehrlich S, Lewin A, Hurwitz A, Simon A. Gonadotropin-releasing hormone (GnRH)-antagonist versus GnRH-agonist in ovarian stimulation of poor responders undergoing IVF. J Assist Reprod Genet 2003 ; 20 : 455-60.
    • (2003) J Assist Reprod Genet , vol.20 , pp. 455-460
    • Fasioloutis, S.J.1    Laufer, N.2    Sabbagh-Ehrlich, S.3    Lewin, A.4    Hurwitz, A.5    Simon, A.6
  • 31
    • 77952955539 scopus 로고    scopus 로고
    • Comparaison of embryological and clinical outcome in GnRH antagonist vs GnRH agonist protocols for in vitro fertilization in PCOS non-obese patients. A prospective randomized study
    • Kurzawa R, Ciepiela P, Baczkowski T, Safranow K, Brelik P. Comparaison of embryological and clinical outcome in GnRH antagonist vs GnRH agonist protocols for in vitro fertilization in PCOS non-obese patients. A prospective randomized study. J Assist Reprod Genet 2008; 25: 365-74.
    • (2008) J Assist Reprod Genet , vol.25 , pp. 365-374
    • Kurzawa, R.1    Ciepiela, P.2    Baczkowski, T.3    Safranow, K.4    Brelik, P.5
  • 32
    • 33751105345 scopus 로고    scopus 로고
    • Efficacy of GnRH antagonist during early and controlled ovarian hyperstimulation period in women with polycystic ovary syndrome undergoing IVF-ET
    • Kim CH, Lee YJ, Hong SH et al. Efficacy of GnRH antagonist during early and controlled ovarian hyperstimulation period in women with polycystic ovary syndrome undergoing IVF-ET. Hum Reprod 2004; 19:105-109.
    • (2004) Hum Reprod , vol.19 , pp. 105-109
    • Kim, C.H.1    Lee, Y.J.2    Hong, S.H.3
  • 33
    • 0034013857 scopus 로고    scopus 로고
    • Increeased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction
    • Westergraad LG, Laursen SB, Andersen CY. Increeased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction. Human Reprod 2000; 15: 1003-8.
    • (2000) Human Reprod , vol.15 , pp. 1003-1008
    • Westergraad, L.G.1    Laursen, S.B.2    Andersen, C.Y.3
  • 34
    • 0028283353 scopus 로고
    • Suppression of the endogenous LH-Surge By The GnRH antagonist Cetrorelix during ovarian stimulation
    • Diedrich K, Diedrich E, Santos E et al. Suppression of the endogenous LH-Surge By The GnRH antagonist Cetrorelix during ovarian stimulation. Hum Reprod 1994; 9: 788-91.
    • (1994) Hum Reprod , vol.9 , pp. 788-791
    • Diedrich, K.1    Diedrich, E.2    Santos, E.3
  • 35
    • 33749595641 scopus 로고    scopus 로고
    • A relative reduction in mid-follicular LH concentrations during GnRH agonist IVF/ICSI cycles leads to lower live birth
    • Lahood R, Al-Jefout M, Tyler J, Ryan J, Driscoll G. A relative reduction in mid-follicular LH concentrations during GnRH agonist IVF/ICSI cycles leads to lower live birth. Hum Reprod 2006; 10: 2645-49.
    • (2006) Hum Reprod , vol.10 , pp. 2645-2649
    • Lahood, R.1    Al-Jefout, M.2    Tyler, J.3    Ryan, J.4    Driscoll, G.5
  • 36
    • 33645833493 scopus 로고    scopus 로고
    • GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol. A systematic review and meta-analysis
    • Griesinger G, Diedrich K, Deveroy P, Kolibianakis EM. GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol. A systematic review and meta-analysis. Hum Reprod Update 2005; 20: 1213-20.
    • (2005) Hum Reprod Update , vol.20 , pp. 1213-1220
    • Griesinger, G.1    Diedrich, K.2    Deveroy, P.3    Kolibianakis, E.M.4
  • 37
    • 4544379545 scopus 로고    scopus 로고
    • [Cedrin-Durnerin I, Grange-Dujardin D, Laffy A, Parneix I, Massin N, Galey J, and al. Recombinant LH supplementation during GnRH antagonist administration in IVF/ICSI cycles. A prospective randomized study. Hum Reprod 2004; 19: 1979-84.
    • [Cedrin-Durnerin I, Grange-Dujardin D, Laffy A, Parneix I, Massin N, Galey J, and al. Recombinant LH supplementation during GnRH antagonist administration in IVF/ICSI cycles. A prospective randomized study. Hum Reprod 2004; 19: 1979-84.
  • 39
    • 33646934306 scopus 로고    scopus 로고
    • Progesterone combined with estradiol as luteal support in cycles stimulated with GnRH antagonist/rec-FSH for IVF. A randomized clinical trial
    • Fatemi H, Kolibianakis EM, Camus M, Tournaye H, Van Steirteghem A, Devroye P. Progesterone combined with estradiol as luteal support in cycles stimulated with GnRH antagonist/rec-FSH for IVF. A randomized clinical trial. Fertil Steril 2005; 84 (supplement 1), S322.
    • (2005) Fertil Steril , vol.84 , Issue.SUPPL.EMENT 1
    • Fatemi, H.1    Kolibianakis, E.M.2    Camus, M.3    Tournaye, H.4    Van Steirteghem, A.5    Devroye, P.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.